MedTrace Logo

Assessment of Coronary Pressure Using the Combined Guidewire and Catheter Wirecath

NCT04776577 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-01-09

No results posted yet for this study

Summary

In summary, the purpose of the study is to evaluate whether the Wirecath device can be used as a standard pressure wire in a safe and efficient way.

Conditions

  • Coronary Disease

Interventions

DEVICE

Wirecath@ and Abbott PressureWire® (20 patients)

Simultaneous FFR measurements with Wirecath@ and Abbott PressureWire®

DEVICE

Wirecath® (20 patients)

FFR measurement with Wirecath® only

DEVICE

Coronary flow reserve

Pressure derived CFR with Wirecath®, Thermodilution CFR with Abbott PressureWire®, Absolut flow CFR with Abbott PressureWire® and Hexacath Rayflow catheter®, Non-invasive echo derived CFR

Sponsors & Collaborators

  • Cavis Technologies AB

    collaborator INDUSTRY

  • Vastra Gotaland Region

    lead OTHER_GOV

Principal Investigators

  • Oskar Angerås, MD PhD · Sahlgrenska University Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-25
Primary Completion
2021-10-25
Completion
2021-10-25

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04776577 on ClinicalTrials.gov